Literature DB >> 15611845

Branched chain amino acids as a parameter for catabolism in treated phenylketonuria.

S Illsinger1, T Lücke, U Meyer, B Vaske, A M Das.   

Abstract

This study was performed to study an association between nutritional status on one hand and BCAA- and Phe-concentrations on the other hand in PKU patients free of infection. AA profiles from 70 PKU patients were measured. 9 patients (subgroup I) with elevated Phe- and BCAA-concentrations as well as 23 patients (subgroup II) with only elevated Phe-levels were included. Dietary records were obtained from both groups; low caloric intake in subgroup I was increased with Duocal or p-am ANAMIX without modifying total protein- and Phe-intake. AA profiles were controlled after 2 weeks. Additionally, we investigated AA profiles from 26 liver transplanted patients with increased carbohydrate and caloric intake as an example for anabolism. In subgroup I Phe- and Isoleu-concentrations decreased sign. After dietary intervention. Leu, Val and Tyr levels decreased not sign. Initial Phe-levels correlated negatively with protein and caloric intake. BCAA concentrations of liver transplanted patients receiving high amounts of carbohydrates were in the lower range of normal. Increased caloric intake lowered most of the elevated Phe- and BCAA- concentrations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15611845     DOI: 10.1007/s00726-004-0150-0

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  6 in total

1.  Predictive equations underestimate resting energy expenditure in female adolescents with phenylketonuria.

Authors:  Meghan E Quirk; Brian J Schmotzer; Rani H Singh
Journal:  J Am Diet Assoc       Date:  2010-06

2.  Protein substitute dosage in PKU: how much do young patients need?

Authors:  A MacDonald; A Chakrapani; C Hendriksz; A Daly; P Davies; D Asplin; K Hall; I W Booth
Journal:  Arch Dis Child       Date:  2006-03-17       Impact factor: 3.791

3.  Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease.

Authors:  Kristen J Skvorak; Harbhajan S Paul; Kenneth Dorko; Fabio Marongiu; Ewa Ellis; Donald Chace; Carolyn Ferguson; K Michael Gibson; Gregg E Homanics; Stephen C Strom
Journal:  Mol Ther       Date:  2009-05-12       Impact factor: 11.454

Review 4.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

5.  Dietary habits and metabolic control in adolescents and young adults with phenylketonuria: self-imposed protein restriction may be harmful.

Authors:  A M Das; K Goedecke; U Meyer; N Kanzelmeyer; S Koch; S Illsinger; T Lücke; H Hartmann; K Lange; H Lanfermann; L Hoy; X-Q Ding
Journal:  JIMD Rep       Date:  2013-11-13

Review 6.  Protein Substitutes in PKU; Their Historical Evolution.

Authors:  Anne Daly; Sharon Evans; Alex Pinto; Catherine Ashmore; Anita MacDonald
Journal:  Nutrients       Date:  2021-02-02       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.